430 related articles for article (PubMed ID: 33160018)
1. The role of Smad signaling cascades in cardiac fibrosis.
Hanna A; Humeres C; Frangogiannis NG
Cell Signal; 2021 Jan; 77():109826. PubMed ID: 33160018
[TBL] [Abstract][Full Text] [Related]
2. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart.
Huang S; Chen B; Su Y; Alex L; Humeres C; Shinde AV; Conway SJ; Frangogiannis NG
J Mol Cell Cardiol; 2019 Jul; 132():84-97. PubMed ID: 31085202
[TBL] [Abstract][Full Text] [Related]
4. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
5. Smad-dependent pathways in the infarcted and failing heart.
Humeres C; Venugopal H; Frangogiannis NG
Curr Opin Pharmacol; 2022 Jun; 64():102207. PubMed ID: 35367786
[TBL] [Abstract][Full Text] [Related]
6. Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
Humeres C; Shinde AV; Hanna A; Alex L; Hernández SC; Li R; Chen B; Conway SJ; Frangogiannis NG
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905511
[TBL] [Abstract][Full Text] [Related]
7. Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
Kong P; Shinde AV; Su Y; Russo I; Chen B; Saxena A; Conway SJ; Graff JM; Frangogiannis NG
Circulation; 2018 Feb; 137(7):707-724. PubMed ID: 29229611
[TBL] [Abstract][Full Text] [Related]
8. TNAP is a novel regulator of cardiac fibrosis after myocardial infarction by mediating TGF-β/Smads and ERK1/2 signaling pathways.
Cheng X; Wang L; Wen X; Gao L; Li G; Chang G; Qin S; Zhang D
EBioMedicine; 2021 May; 67():103370. PubMed ID: 33971401
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.
Russo I; Frangogiannis NG
J Mol Cell Cardiol; 2016 Jan; 90():84-93. PubMed ID: 26705059
[TBL] [Abstract][Full Text] [Related]
10. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts and the extracellular matrix in right ventricular disease.
Frangogiannis NG
Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
[TBL] [Abstract][Full Text] [Related]
12. Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.
Chen YH; Wang Q; Li CY; Hou JW; Chen XM; Zhou Q; Chen J; Wang YP; Li YG
J Mol Cell Cardiol; 2017 Apr; 105():1-11. PubMed ID: 28214509
[TBL] [Abstract][Full Text] [Related]
13. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F; Liu C; Zhou D; Zhang L
J Histochem Cytochem; 2016 Mar; 64(3):157-67. PubMed ID: 26747705
[TBL] [Abstract][Full Text] [Related]
14. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
Wang L; Shi H; Huang JL; Xu S; Liu PP
Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
[TBL] [Abstract][Full Text] [Related]
15. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
16. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation.
Chen B; Huang S; Su Y; Wu YJ; Hanna A; Brickshawana A; Graff J; Frangogiannis NG
Circ Res; 2019 Jun; 125(1):55-70. PubMed ID: 31092129
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling.
Ma Y; de Castro Brás LE; Toba H; Iyer RP; Hall ME; Winniford MD; Lange RA; Tyagi SC; Lindsey ML
Pflugers Arch; 2014 Jun; 466(6):1113-27. PubMed ID: 24519465
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β in myocardial disease.
Frangogiannis NG
Nat Rev Cardiol; 2022 Jul; 19(7):435-455. PubMed ID: 34983937
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
